26
|
Loi M, Simontacchi G, Detti B, Di Cataldo V, Bonomo P, Masi L, Doro R, Bonucci I, Cipressi S, Desideri I, Greto D, Becherini C, Delli Paoli C, Grassi R, Lo Russo M, Meattini I, Scoccianti S, Mangoni M, Livi L. EP-1352: Single-fraction stereotactic body radiotherapy for nodal oligorecurrent prostate cancer. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31787-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
27
|
Di Cataldo V, Simontacchi G, Detti B, Loi M, Bonomo P, Masi L, Doro R, Bonucci I, Cipressi S, Greto D, Mangoni M, Desideri I, Meattini I, Scoccianti S, Olmetto E, Muntoni C, Carta G, Livi L. EP-1350: Stereotactic re-irradiation for prostate cancer recurrence after upfront surgery and radiotherapy. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31785-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
28
|
Desideri I, Muntoni C, Ciabatti C, Lo Russo M, Bonomo P, Loi M, Greto D, Meattini I, Livi L. EP-1087: Real-world Cetuximab toxicity in curative and recurrent/metastatic setting in HNSCC patients. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31523-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
Greto D, Loi M, Scoccianti S, Baki M, Desideri I, Bordi L, Bono P, Meattini I, Bonomo P, Terziani F, Carfora V, Livi L. PO-0624: Gammaknife Radiosurgery in patients receiving anticancer immunotherapy: efficacy and safety. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31061-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
30
|
Desideri I, Bonomo P, Ciabatti C, Muntoni C, Lo Russo M, Loi M, Greto D, Meattini I, Livi L. PO-148: Hypofractionated radiotherapy for head and neck cancer patients unfit for standard treatment. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)30282-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
31
|
Meattini I, Saieva C, Miccinesi G, Desideri I, Marrazzo L, Loi M, Meacci F, Muntoni C, Greto D, Topulli J, Nori J, Bernini M, Sanchez L, Orzalesi L, Mangoni M, Pallotta S, Bianchi S, Livi L. Health-related quality of life analysis from the accelerated partial breast irradiation IMRT-Florence phase 3 trial: Impact of age and scores trend over time. Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30106-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Loi M, Olmetto E, Desideri I, Meattini I, Francolini G, Greto D, Bonomo P, Di Brina L, Becherini C, Muntoni C, Mangoni M, Livi L. BRCA1/2 mutation in breast cancer: biological aspects, patterns of care and impact on outcome in a monoinstitutional cohort. Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30141-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
33
|
Bonomo P, Isacco D, Loi M, Carfora V, Cipressi S, Di Cataldo V, Masi L, Doro R, Bonucci I, Simontacchi G, Greto D, Scoccianti S, Livi L. Stereotactic re-irradiation for recurrent head and neck cancer: predictive factors of efficacy from a single-institution experience. Eur J Cancer 2017. [DOI: 10.1016/s0959-8049(17)30442-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
34
|
Meattini I, Bicchierai G, Saieva C, De Benedetto D, Desideri I, Becherini C, Abdulcadir D, Vanzi E, Boeri C, Gabbrielli S, Lucci F, Sanchez L, Casella D, Bernini M, Orzalesi L, Vezzosi V, Greto D, Mangoni M, Bianchi S, Livi L, Nori J. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature. Eur J Surg Oncol 2016; 43:642-648. [PMID: 27889196 DOI: 10.1016/j.ejso.2016.10.025] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2016] [Revised: 10/01/2016] [Accepted: 10/31/2016] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND Core needle biopsy (CNB) plays a crucial role as diagnostic tool for breast cancer (BC). The characterization of biomarkers status before surgical treatment is crucial when primary systemic therapy is a therapeutic option. The aim of this analysis was to report concordance between preoperative CNB and surgical specimen (SS) in evaluating biomarkers and molecular subtypes. METHODS Data have been collected from a cohort of 101 patients affected by early BC treated at Careggi Florence University Hospital, between January 2014 and March 2015. The conformity between molecular subtype classification was tested using kappa (κ) test. RESULTS Mean age was 57.5 years (range 29-86). There was concordance between the estrogen receptor (ER) assessment on CNB and SS in 95 cases (94.1%). Concordance of the progesterone receptor (PgR) assessment was observed in 89 cases (88.1%). Concordance for detecting immunohistochemistry-assessed BC molecular subtypes was 87.1% (κ = 0.78). Concerning Ki-67 evaluation, we report a concordance rate of 88.1% (κ = 0.68). The evaluation of luminal A plus luminal B/HER negative subgroup showed a κ-value of 0.65. CONCLUSIONS CNB showed good accuracy in evaluating hormonal receptors status, HER2, and BC molecular subtypes. Evaluation of Ki67 status was less accurate than other biomarkers; therefore, we recommend that it should be detected both on CNB and SS samples, especially in hormonal positive HER2 negative tumors, in order to avoid a misclassification of tumor subtypes that could lead to an omission of potential effective systemic therapy.
Collapse
|
35
|
Sanfilippo E, Galeotti C, Cornacchione P, Wandael Y, Nacca A, Morroni M, Onorati B, Greto D, Bonomo P, Groccia N, D'Angelillo R, Ramella S, Meattini I, Livi L. EP-2116: Optimization of whole breast irradiation setup: comparison between two different positioning systems. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)33367-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
36
|
Meattini I, Livi L, Bastiani P, Scotti V, Paoletti L, De Luca Cardillo C, Barca R, Greto D, Martella F, Simontacchi G, Tinacci G, Nori J, Smith H, Sanchez L, Galli L, Orzalesi L, Fondelli S, Bianchi S, Rossi F. EP-1156: Radiotherapy for ductal carcinoma in situ: patterns of recurrence and risk factors stratification. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32406-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
37
|
Scoccianti S, Simontacchi G, Talamonti C, Compagnucci A, Casati M, Arilli C, Greto D, Meacci F, Bonomo P, Desideri I, Carta G, Loi M, Livi L. EP-1665: Scalp-Sparing focal radiotherapy for gliomas using VMAT or Helical Tomotherapy: a feasibility study. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32916-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Casati M, Compagnucci A, Arilli C, Marrazzo L, Simontacchi G, Greto D, Pallotta S, Talamonti C. EP-1507: Which detector for small photon field measurements? Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32757-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
39
|
Greto D, Loi M, Ciabatti C, Mancuso A, Muntoni C, Grassi R, Giacomelli I, Capanna R, Campanacci D, Beltrami G, Scoccianti G, Franchi A, Livi L. EP-1400: Combined modality management of myxofibrosarcomas: a single-institution experience. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32650-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Calusi S, Noferini L, Casati M, Marrazzo L, Arilli C, Compagnucci A, Talamonti C, Scoccianti S, Greto D, Bordi L, Livi L, Pallotta S. EP-1514: γTools: a new multipurpose phantom for end-to-end tests in Gamma Knife SRS treatments. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32764-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
41
|
Mangoni M, Sottili M, Gerini C, Morroni M, Desideri I, Bonomo P, Loi M, Greto D, Capanna R, Beltrami G, Campanacci D, Livi L. 624 Inhibition of poly(ADP-ribose) polymerase-1 radio-sensitizes human soft tissue sarcoma cells. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30360-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
42
|
Talamonti C, Casati M, Compagnucci A, Arilli C, Greto D, Marrazzo L, Pallotta S, Zani M, Marinelli M, Menichelli D, Scotti L, Verona G. SU-E-T-506: Intercomparison Study On Small Field Output Factor Measurements. Med Phys 2015. [DOI: 10.1118/1.4924868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
43
|
Greto D, Scoccianti S, Compagnucci A, Arilli C, Casati M, Francolini G, Cecchini S, Loi M, Bordi L, Bono P, Detti B, Livi L. EP-1357: GammaKnife Radiosurgery in the management of single and multiple brain metastases. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41349-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
44
|
Scoccianti S, Greto D, Francolini G, Desideri I, Cecchini S, Loi M, Casati M, Arilli C, Compagnucci A, Simontacchi G, Bonomo P, Bordi L, Bono P, Livi L. PO-0807: Radiosurgery and brain metastases: high-resolution MRI can significantly change intracranial disease staging. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40799-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
45
|
Scoccianti S, Greto D, Bordi L, Bono P, Pecchioli G, Casati M, Vanzi E, Compagnucci A, Gadda D, Livi L. O7.02 * RADIOSURGERY AND BRAIN METASTASES: ADEQUATE SEQUENCE OF BRAIN MRI CAN SIGNIFICANTLY CHANGE THE INTRACRANIAL DISEASE STAGING. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.53] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Detti B, Scoccianti S, Greto D, Cassani S, Cappelli S, Giacomelli I, Bordi L, Di cataldo V, Monteleone E, Livi L. P06.13 * OUTCOME AND PROGNOSTIC FACTORS IN ATYPICAL AND MALIGNANT MENINGIOMA: UNIVERSITY OF FLORENCE EXPERIENCE. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Greto D, Bonomo P, Detti B, Scoccianti S, Cipressi S, Cassani S, Giacomelli I, Cappelli S, Franceschini D, Livi L. P13.22 * CYBERKNIFE STEREOTACTIC RADIOSURGERY FOR THE RE-IRRADIATION OF BRAIN LESIONS: A SINGLE-CENTRE EXPERIENCE. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Greto D, Pallotta S, Masi L, Talamonti C, Doro R, Scoccianti S, Marrazzo L, Meattini I, Bonomo P, Livi L. PO-0982: Dosimetric comparison between Tomotherapy and Cyberknife for radiosurgery of single brain metastasis. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31100-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
49
|
Meattini I, Livi L, Franceschini D, Saieva C, Meacci F, Marrazzo L, Bendinelli B, Scotti V, De Luca Cardillo C, Nori J, Sanchez L, Orzalesi L, Bonomo P, Greto D, Bucciolini M, Bianchi S, Biti G. Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients. Eur J Surg Oncol 2013; 39:613-8. [DOI: 10.1016/j.ejso.2013.03.002] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2012] [Revised: 02/16/2013] [Accepted: 03/04/2013] [Indexed: 11/27/2022] Open
|
50
|
Bonomo P, Franceschini D, Paiar F, Loi M, Meattini I, Agresti B, Monteleone Pasquetti E, Greto D, Livi L, Biti G. PO-068: Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) in the Treatment of H&N Cancer. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)34687-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|